MUC1 and neoplasm: The results showed that in comparison to the iPSC-NK cells (P < 0.001) and blank control groups (P < 0.01), the xenograft tumor in the iPSC-derived MUC1-targeted CAR-NK cell group exhibited significantly slower growth (Figure 1A left).